Would you like an email update sent to your inbox?


We've achieved another milestone in our mission to achieve better and safer treatment for our heart patients.


Called TricValve, this minimally invasive treatment is targeted at patients with heart failure due to tricuspid regurgitation (TR) or severe 'leaky' heart valves, and who are unsuitable for open-heart surgery.

This procedure was recently performed at Mount Elizabeth Hospital on 26 May 2022 and is the first for a private hospital in Singapore and Southeast Asia. Supported by an experienced team of nurses and radiographers, the procedure was successfully performed by cardiologists Dr Paul Chiam, Dr Charles Chan, and Dr Lim Choon Pin.

Involving a brief hospital stay, TricValve is a minimally invasive procedure that involves the implantation of 2 specially designed self-expanding valves via a blood vessel in the leg and placing them close to the chambers in the right side of the heart. These valves then expand in place to reduce the abnormal back flow of blood into the liver, kidney, neck, and head veins.

This doesn't just improve treatment outcomes for our heart patients with severe TR, but also focuses on their safety while helping them achieve a quicker recovery!

Get in touch with our colleagues in our representative offices to find out more about TricValve, and other minimally invasive treatments for heart diseases in Singapore today.

Other Related Articles 

A Heart Surgery that Does Not Cut Your Chest Open

Read More

Paying for Heart Surgery in Singapore with MediSave & Insurance

Read More

Keyhole Surgery to Repair Heart Valves

Read More

TAVI/TAVR: New Hope for Elderly Heart Patients

Read More

Scan to check our services and profile

Parkway Hospitals Singapore

Philippine Office

G/F-B, Marco Polo Hotel, Meralco Avenue, Ortigas Center,  Pasig City

Philippines 1600

0917 705 7061 | 0917 526 7576

Copyright © 2022 Parkway Holdings Ltd.

SingCare Philippines Corporation

SEC Registration No: CS202006955